Literature DB >> 20974025

Multiple physician recommendations for prostate cancer treatment: a Pandora's box for patients?

Willie Underwood1, Heather Orom, Michael Poch, Brady T West, Paula M Lantz, Sam S Chang, Jay H Fowke.   

Abstract

OBJECTIVE: Patients turn to their physicians for information and guidance when making a prostate cancer treatment decision. The objectives of this study were to determine the likelihood of men consulting with and receiving treatment recommendations from different providers (urologists, radiation oncologists, and primary care physicians), the content of these recommendations, the perceived influence of recommendations and which recommendations, if any, were associated with prostate cancer treatment decisions.
METHODS: One hundred and fifty-eight participants with localized prostate cancer completed a survey regarding their treatment decision-making process. Associations between treatment choice and urologist recommendations, consultations with radiation oncologists and primary care physicians, potential side effects and other factors were examined using regression analysis.
RESULTS: Among men consulting multiple providers, more than half received at least one treatment recommendation. Most men chose a treatment recommended by at least one provider. The likelihood of choosing a treatment increased when the urologist recommended it. Consulting a radiation oncologist decreased and increased likelihood of choosing a radical prostatectomy and radiation, respectively.
CONCLUSION: Most men consulted multiple providers and received multiple treatment recommendations. Recommendations appear to play a significant role in prostate cancer treatment decision-making.

Entities:  

Mesh:

Year:  2010        PMID: 20974025

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  6 in total

1.  Patient Decision Making Prior to Radical Prostatectomy: What Is and Is Not Involved.

Authors:  Çağatay Doğan; Hamza M Gültekin; Sarper M Erdoğan; Hamdi Özkara; Zübeyr Talat; Ahmet N Erözenci; Can Öbek
Journal:  Am J Mens Health       Date:  2016-09-21

2.  Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer.

Authors:  Kimberly Davis; Paula Bellini; Charlotte Hagerman; Riley Zinar; Daniel Leigh; Richard Hoffman; David Aaronson; Stephen Van Den Eeden; George Philips; Kathryn Taylor
Journal:  Urology       Date:  2017-04-25       Impact factor: 2.649

3.  Is "Active Surveillance" an Acceptable Alternative?: A Qualitative Study of Couples' Decision Making about Early-Stage, Localized Prostate Cancer.

Authors:  Yen-Chi L Le; Stephanie L McFall; Theresa L Byrd; Robert J Volk; Scott B Cantor; Deborah A Kuban; Patricia Dolan Mullen
Journal:  Narrat Inq Bioeth       Date:  2016

4.  Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.

Authors:  Kathryn L Taylor; Richard M Hoffman; Kimberly M Davis; George Luta; Amethyst Leimpeter; Tania Lobo; Scott P Kelly; Jun Shan; David Aaronson; Catherine A Tomko; Amy J Starosta; Charlotte J Hagerman; Stephen K Van Den Eeden
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-06-02       Impact factor: 4.254

5.  Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.

Authors:  Emily M Mader; Hsin H Li; Kathleen D Lyons; Christopher P Morley; Margaret K Formica; Scott D Perrapato; Brian H Irwin; John D Seigne; Elias S Hyams; Terry Mosher; Mark T Hegel; Telisa M Stewart
Journal:  BMC Urol       Date:  2017-05-08       Impact factor: 2.264

6.  Mind the gap: Physicians' assessment of patients' importance weights in localized prostate cancer.

Authors:  Katya Tentori; Stefania Pighin; Claudio Divan; Vincenzo Crupi
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.